HUMAN AUTOCELL
LIVER CELL REGENERATION PROCEDURE
Background to the Procedure
The General Cell Regeneration procedure to arrest cirrhosis is simple and safe. A tissue sample is excised from the patient’s liver, and the healthy cells are isolated. Using ‘scaffolding technology’, the cells are seeded in vitro on Human Autocell’s unique, patented Porocell matrix.
Seeding is rapid and takes a few days before the matrix is implanted into the patient’s abdominal cavity. The matrix is biodegradable and degrades over time in the patient’s body with no ill effects.
With many successful procedures carried out to date, the technique is proven, fast, and improves the quality of life. Patients typically recover over a fourteen-day period.
A SHORT HISTORY
Human Autocell started in 2003 as an R&D firm involved in the development of cell regeneration techniques.
Breakthorugh Scaffold Technology
Its first breakthrough came when the team successfully used scaffold technology to grow cell cultures in vitro in its labs.
Over 75 Patients Treated
The company developed this into a procedure approved for 75 patients in Germany; a highly efficient treatment for a disease that requires transplantation.
human autocell
RESOURCES
Human Autocell holds global patents and published papers on its findings. Studies look at traditional methods of managing liver cirrhosis, such as abiotic artificial livers, bio-artificial livers, compound artificial livers and transplantation. The relative merits and demerits of these treatments are compared to the advanced work on cell regeneration in vitro growth using Human Autocell’s patented 3D cell regeneration procedure. Resources include references to the following research areas:
Latest Liver Cirrhosis and Cell Regeneration Research and Development
Hepatic Regeneration in Cirrhosis
Mesenchymal Stem Cells for Liver Regeneration in Liver Failure
Cell Therapy, Liver Diseases, and Regeneration
Emerging Synthetic Drugs for the Treatment of Liver Cirrhosis
Mfap4: A Promising Target for Enhanced Liver Regeneration
Latest Advancements in Cell Therapy for Liver Cirrhosis
Macrophage Cell Therapy
Mesenchymal Stem Cell (MSC) Therapy
Combination Therapies and Novel Approaches
Clinical Trials and Future Directions
Impact of the Regeneration Capacity of the Liver on Effectiveness of Cell Therapy
Cell Replacement and Remodeling
Challenges in Chronic Conditions
Cell Quality and Function
Innovative Approaches
Improving the Efficiency of Cell Therapy for Liver Diseases
Enhancing Cell Sources and Quality
Stem Cell Utilization
Organoids and Progenitor Cell stem Cell Utilization
Optimizing Cell Delivery Methods
Targeted Delivery
Use of Biomaterials
Modulating the Immune Response
Immunosuppression Strategies
Cytokine Stimulation
Promoting Cellular Rejuvenation
Reprogramming Factors
Clinical Trials and Research
Ongoing Clinical Trials
Addressing Barriers
Need help?
Please get in touch to learn more about working together
For enquiries, please call
+44 1932 481 444
email: